(Q44183238)

English

The human amylin analog, pramlintide, reduces postprandial hyperglucagonemia in patients with type 2 diabetes mellitus

scientific article published in September 2002

Statements

The human amylin analog, pramlintide, reduces postprandial hyperglucagonemia in patients with type 2 diabetes mellitus (English)
1 September 2002
504-508

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit